Skip to main content

Month: September 2021

InflaRx to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

JENA, Germany, Sept. 09, 2021 (GLOBE NEWSWIRE) — InflaRx (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announces that Prof. Niels C. Riedemann, Chief Executive Officer and Founder, will present a company overview at the H.C. Wainwright 23rd Annual Global Investment Conference, which is being held virtually. The presentation will be available on demand starting at 7:00 AM EDT / 1:00 PM CET on Monday, September 13, 2021. A webcast of the event will be available for 90 days on the InflaRx website in the Investors section under Events & Presentations. About InflaRx N.V.:InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent...

Continue reading

DraftKings Launches Online Sports Betting in Arizona

Arrival of Top-Rated Mobile Sportsbook App Follows Successful Daily Fantasy Sports Debut BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) announced today the launch of DraftKings’ online Sportsbook in Arizona, marking the 14th state in which the top-rated mobile sportsbook is available. Arizona sports fans age 21 and over are now able to place wagers on a variety of betting markets across professional, collegiate and other sports leagues via the DraftKings Sportsbook app. The announcement comes following a successful launch of DraftKings’ daily fantasy product which experienced more than 90,000 contest entries in the first 12 days. “With the launch of our digital sportsbook coinciding with NFL kickoff, the busiest and most exciting time of the year for our company, we could not have imagined a better time...

Continue reading

Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104

Anita H. Clayton, MD, joins Scientific Advisory Board TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; NASDAQ: FTRP) (“Field Trip”), a global leader in the development and delivery of psychedelic therapies, announced today the lead indications for FT-104, its novel psychedelic compound in development, will be Treatment Resistant Depression (TRD) and Postpartum Depression (PPD). Field Trip today also announced that Anita H. Clayton, MD, Chair of Psychiatry and Neurobehavioral Sciences at the School of Medicine at the University of Virginia, has joined its Scientific Advisory board. Through Field Trip Discovery, its drug development division, Field Trip is developing next-generation psychedelic molecules. Its first molecule in development, FT-104, a prodrug, is a synthetic serotonin-2A...

Continue reading

Dynamic Technologies Group Announces USD $5.7 million Contract Award

Flying Theater contract expected to be completed by second quarter 2022 TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Dynamic Technologies Group Inc. (TSXV: DTG, OTC:ERILF) ( the “Company”) today announced that it has been awarded a USD $5.7 million ride system contract to supply a flying theater for a tourist based location in California. The project is being fast-tracked, expected to be completed by the second quarter of 2022. “It is satisfying to see this new contract award in 2021,” said Guy Nelson, Executive Chairman and Chief Executive Officer. “This is a positive sign that the market for attractions is returning after more than a year of near shutdown for theme parks and location based entertainment attractions due to the global pandemic.” About Dynamic Technologies Group Inc. Dynamic is a world leader in the design engineering,...

Continue reading

Blueberries Medical Announces Closing of C$ 2.1 Million Non-Brokered Private Placement and the Appointment of New Director

TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces the completion of a non-brokered private placement consisting of the sale of 20,813,817 common shares (“Common Shares”) at a price of C$0.10 per Common Share for aggregate gross proceeds of C$1,901,382 (or approximately US$1,500,000) (the “Offering”), of which 19,013,817 Common Shares was paid for in cash and 1,800,000 Common Shares was issued in connection for past services provided to the Company by an arm’s length third party service provider. Following the successful control of the Company’s SG&A over the past six months and improvements to operational standards in both cultivation...

Continue reading

Osino Provides Update on Development Studies at Twin Hills Gold Project, Namibia

HighlightsSignificant progress made with utilities (power & water), metallurgy and tailings designOffer received from Namibia’s power utility for high voltage grid power supply Bulk water supply application submitted to Namibia’s water utility Progress made with water supply drilling and groundwater modelling Progress made with dry-stack tailings dam design to reduce water consumption Additional met testwork towards process plant optimization underwayResource definition and exploration drilling on-going with 8 drill rigs 90,000m drilled year-to-date with additional 20,000m planned until December 2021 Assay results for ~8,000m of infill and brownfields exploration drilling outstandingVANCOUVER, B.C., Sept. 09, 2021 (GLOBE NEWSWIRE) — Osino Resources Corp. (TSXV:OSI) (FSE:RSR1) (OTCQX:OSIIF) (“Osino” or “the...

Continue reading

DAVIDsTEA expands presence with “store-within-a-store” concept in Rexall pharmacies

The best of DAVIDsTEA tea sachets and pre-packs conveniently available at Rexall pharmacies across CanadaFALL21_DavidsTea+RexallDAVIDsTEA expands presence with “store-within-a-store” concept in RexallMONTRÉAL, Sept. 09, 2021 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (Nasdaq:DTEA), a leading tea merchant in North America, is pleased to announce the expanded availability of its tea sachets, pre-packs and samplers in over 110 Rexall pharmacies, a leading Canadian drugstore operator. Following a successful pilot launched in March of this year, DAVIDsTEA has expanded its presence from 5 to 46 Rexall locations in Central Canada since June. With 69 more locations being added in Rexall stores in Canada this September, DAVIDsTEA is confident that Rexall’s “store-within-a-store” concept will help to further strengthen its brand...

Continue reading

Matrix Service Company To Present at Upcoming D.A. Davidson and Sidoti Virtual Investor Conferences

TULSA, Okla., Sept. 09, 2021 (GLOBE NEWSWIRE) — Matrix Service Company (Nasdaq: MTRX) announced today that President and Chief Executive Officer John R. Hewitt and Vice President and Chief Financial Officer Kevin Cavanah will be presenting at the D.A. Davidson 20th Annual Diversified Industrials & Services Conference on September 22, 2021 at 5pm Eastern Standard Time and at the Sidoti Fall Small Cap Investor Conference on September 23, 2021 at 10:00 a.m. Eastern Standard Time. One-on-one meetings with management are available during both conferences with prior notice and may be scheduled through the conferences or by contacting Matrix Service Company at ir@matrixservicecompany.com. About Matrix Service Company Matrix Service Company (Nasdaq: MTRX), through its subsidiaries, is a leading North American industrial engineering...

Continue reading

Wesana Health Announces Closing of PsyTech Acquisition

Company also provides update on potential U.S. listing CHICAGO and TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including through the advancement of psychedelic medicines, today announced the closing on September 8, 2021 of its acquisition of Psychedelitech Inc., also known as PsyTech (the “Transaction”). “The team at PsyTech has developed a leading platform for the treatment of neurological health that significantly accelerates Wesana’s technical capabilities and go-to-market strategy,” commented Daniel Carcillo, Chief Executive Officer of Wesana Health. “With the closing...

Continue reading

Entourage Health Launches Fire & Flower-branded CBD Softgel Product Line

Canada’s largest cannabis retailer Fire & Flower expands private-label portfolio with “Revity CBD Softgel” products added to its self-care lineup, produced exclusively by Entourage Health TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, in collaboration with leading Canadian retailer Fire & Flower Inc. (“Fire & Flower”) (TSX:FAF; OTCQX:FFLWF), is pleased to announce the release of Fire & Flower’s “Revity CBD™ Softgel” line. In addition to the CBD softgels, the private-label Revity product line currently includes CBD oils launched last year. Revity CBD products are available in Saskatchewan retail locations and will expand...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.